Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02092727 · ClinicalTrials.gov registry record · NA

The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) Community Study

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
134
Enrollment target

NCT02092727 is a NA study that has completed, run by Emory University. The registered enrollment target is 134 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02092727, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
134 participants
Enrollment target

Study Summary

The Southeastern Kidney Transplant Coalition is an academic-community collaboration between partners in the kidney disease community who share the common goal of eliminating health disparities in access to kidney transplantation among African American End Stage Renal Disease living in Georgia, North Carolina, and South Carolina. Volunteer members of this community-based coalition include patients with kidney disease, dialysis facility staff and providers, transplant centers, quality improvement organizations, and patient advocacy organizations. The burden of kidney disease is highest in the Southeast, and yet the rate of kidney transplantation is the lowest in the nation. Further, the investigators research suggests that racial disparities in access to kidney transplantation are concentrated in the Southeast, where African Americans are less likely to access each step in the transplant process. The long-term goal of the investigators Coalition is to use community- based participatory research approaches to develop, test, and disseminate sustainable, community interventions improve access to transplant for African American patients with kidney disease. The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) community study proposes to use community-based participatory research methods to develop a multilevel intervention to reduce racial disparities in access to kidney transplantation. The long-term impact of this application will be to reduce racial disparities in the kidney disease community.

Interventions

  • BEHAVIORAL Behavioral Interventions for Dialysis Facilities

Trial Details

FieldValue
Enrollment Target 134 participants
Start Date 2014-02
Est. Completion 2018-01
Phase NA

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02092727

The ClinicalTrials.gov registry entry for NCT02092727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Behavioral Interventions for Dialysis Facilities is the first listed.

NCT02092727 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02092727 about?

NCT02092727 is a clinical study titled "The Reducing Disparities in Access to kidNey Transplantation (RaDIANT) Community Study". The Southeastern Kidney Transplant Coalition is an academic-community collaboration between partners in the kidney disease community who share the common goal of eliminating health disparities in access to kidney transplantation among African American End Stage Renal Disease living in Georgia, North...

What is the current status of trial NCT02092727?

This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2014-02. Estimated completion is 2018-01.

What interventions are being tested in trial NCT02092727?

The interventions under investigation include: Behavioral Interventions for Dialysis Facilities (BEHAVIORAL).

Who is sponsoring clinical trial NCT02092727?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.